CN109602750A - 一种治疗皮肤病的外用药 - Google Patents
一种治疗皮肤病的外用药 Download PDFInfo
- Publication number
- CN109602750A CN109602750A CN201811272875.1A CN201811272875A CN109602750A CN 109602750 A CN109602750 A CN 109602750A CN 201811272875 A CN201811272875 A CN 201811272875A CN 109602750 A CN109602750 A CN 109602750A
- Authority
- CN
- China
- Prior art keywords
- externally applied
- applied drug
- skin
- dermopathic externally
- qumixin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Abstract
本发明的一种治疗皮肤病的外用药是将酮康唑,糠酸莫米松,盐酸特比萘芬,曲咪新乳膏四种药品按先后顺序1:1:1:1的比例研磨混合制成的药膏。本发明的一种治疗皮肤病的外用药对各类皮肤病能有效止痒、消炎;尤其对病程长、久治不愈的顽固性皮肤病有药到病除的功效,能让患者的皮肤病不再复发,恢复健康皮肤。
Description
技术领域
本发明涉及一种外用药品,尤其涉及一种治疗皮肤病的外用药。
背景技术
皮肤是人体最大的器官,在维护机体的健康上,起到十分重要的作用。当皮肤的生理功能受到损害时就会引起皮肤病。皮肤病是人们多发的常见疾病,皮肤病的种类不但繁多,而且有的皮肤病原因很复杂,经久不愈,给人们生活上、工作上及精神上带来了一定的不便和痛苦;尤其是有的慢性皮肤病的病程长达数十年之久,长期瘙痒,严重困扰者患者。而现市面上的针对皮肤病的外用药膏虽能止痒,但需要时间长,止痒后也不能有效的快速治愈;且具有顽固性皮肤病的患者在用药后也容易复发。
发明内容
本发明的目的是为了解决现有技术中所存在的缺陷,提供一种不仅能快速止痒,且能快速治愈,让皮肤病不复发的一种治疗皮肤病的外用药。
为实现上述目的,本发明提供如下技术方案:一种治疗皮肤病的外用药,所述一种治疗皮肤病的外用药的原料成分包括酮康唑,糠酸莫米松,盐酸特比萘芬,曲咪新乳膏。
优选的,所述原料成分酮康唑,糠酸莫米松,盐酸特比萘芬,曲咪新乳膏的重量比分别为4-8g、3-12g、2-7g和3-9g。
优选的,所述原料成分最佳重量比为:酮康唑5g、糠酸莫米松5g、盐酸特比萘芬5g和曲咪新乳膏5g。
优选的,所述一种治疗皮肤病的外用药的制备步骤为按原料成分的最佳重量比称取酮康唑,糠酸莫米松,盐酸特比萘芬,曲咪新乳膏四种药品并按先后顺序研磨混合制成。
优选的,所述一种治疗皮肤病的外用药为药膏状。
与现有技术相比,本发明提供了一种治疗皮肤病的外用药,具备以下有益效果:对接触性皮炎,过敏性皮炎,真菌感染的各类皮肤病能有效止痒、消炎;尤其对病程长、久治不愈的顽固性皮肤病有药到病除的功效,能让患者的皮肤病不再复发,恢复健康皮肤。
具体实施方式
下面将对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。
实施例1,一种治疗皮肤病的外用药,所述一种治疗皮肤病的外用药的原料成分包括酮康唑,糠酸莫米松,盐酸特比萘芬,曲咪新乳膏。所述原料成分酮康唑,糠酸莫米松,盐酸特比萘芬,曲咪新乳膏的重量比分别为4-8g、3-12g、2-7g和3-9g。所述原料成分最佳重量比为:酮康唑5g、糠酸莫米松5g、盐酸特比萘芬5g和曲咪新乳膏 5g,即原料成分酮康唑,糠酸莫米松,盐酸特比萘芬,曲咪新乳膏的最佳比例为1:1:1:1。所述一种治疗皮肤病的外用药的制备步骤为将酮康唑,糠酸莫米松,盐酸特比萘芬,曲咪新乳膏四种药品按1: 1:1:1的比例称取并按先后顺序研磨混合制成。所述一种治疗皮肤病的外用药为药膏状。
一种治疗皮肤病的外用药的治疗效果与原料成分的重量比有关:
当一种治疗皮肤病的外用药的原料成分的比例为1:1:1:1时,制备出来的一种治疗皮肤病的外用药的能快速治疗各种皮肤病且让患者不再复发。
实施例2,在社会群体中,找到多年不愈的顽固性皮炎患者,其中男、女、老、少各二十个,使用实施例1制备的一种治疗皮肤病的外用药,将一种治疗皮肤病的外用药涂抹在患处,用完该药一段时间后治愈了患者的顽固性皮炎。
实施例3,在正规医疗单位,从医多年的医护人员群体中,有很多患有接触顽固性皮炎且经多年的皮肤病常规治疗但无效的患者,使用实施例1制备的一种治疗皮肤病的外用药涂抹在患处一段时间后治愈不复发。
实施例4,在医疗单位皮肤科门诊找到具有不同久治不愈的顽固性皮肤病患者,让其将实施例1制备的一种治疗皮肤病的外用药涂抹在患处,用完一段时间后不同顽固性皮肤病的不同患者被治愈且皮肤病不复发。
实施例5,在不同地域、不同种族、不同国界,将实施例1制备的一种治疗皮肤病的外用药经过免费快递给有需要的皮肤病患者,患者将一种治疗皮肤病的外用药涂抹在患处,不同地域、不同种族、不同国界的皮肤病患者使用后均被治愈,顽固性皮肤病患者不复发。
实施例6,选取不同的男女皮肤病患者各20名,将上述实施例1 制备的一种治疗皮肤病的外用药跟999皮炎平、达克宁和皮康王进行为期一个月的治疗效果的对比,实验结果如下:
根据上述实施例中的一种治疗皮肤病的外用药的实验结果,可得知:一种治疗皮肤病的外用药经大量的不同人群,不同地域,不同种类的临床试验组证实其疗效是肯定的;一种治疗皮肤病的外用药在疗效方面,具有比其他相似产品999皮炎平,达克宁,皮康王,皮炎松等对顽固性皮肤病有药到病除而且不复发的特效。一种治疗皮肤病的外用药对接触性皮炎,过敏性皮炎,真菌感染的各类皮肤病有效;尤其对病程长,久治不愈的顽固性皮肤病有药到病除的功效。
上述实施例为本发明较佳的实施方式,但本发明的实施方式并不受上述实施例的限制,其它的任何未背离本发明的精神实质与原理下所作的改变、修饰、替代、组合、简化,均应为等效的置换方式,都包含在本发明的保护范围之内。
Claims (5)
1.一种治疗皮肤病的外用药,其特征在于:所述一种治疗皮肤病的外用药的原料成分包括酮康唑,糠酸莫米松,盐酸特比萘芬,曲咪新乳膏。
2.根据权利要求1所述的一种治疗皮肤病的外用药,其特征在于:所述原料成分酮康唑,糠酸莫米松,盐酸特比萘芬,曲咪新乳膏的重量比分别为4-8g、3-12g、2-7g和3-9g。
3.根据权利要求2所述的一种治疗皮肤病的外用药,其特征在于:所述原料成分最佳重量比为:酮康唑5g、糠酸莫米松5g、盐酸特比萘芬5g和曲咪新乳膏5g。
4.根据权利要求1所述的一种治疗皮肤病的外用药,其特征在于:所述一种治疗皮肤病的外用药的制备步骤为按原料成分的最佳重量比称取酮康唑,糠酸莫米松,盐酸特比萘芬,曲咪新乳膏四种药品并按先后顺序研磨混合制成。
5.根据权利要求1所述的一种治疗皮肤病的外用药,其特征在于:所述一种治疗皮肤病的外用药为药膏状。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811272875.1A CN109602750A (zh) | 2018-10-25 | 2018-10-25 | 一种治疗皮肤病的外用药 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811272875.1A CN109602750A (zh) | 2018-10-25 | 2018-10-25 | 一种治疗皮肤病的外用药 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109602750A true CN109602750A (zh) | 2019-04-12 |
Family
ID=66002110
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811272875.1A Pending CN109602750A (zh) | 2018-10-25 | 2018-10-25 | 一种治疗皮肤病的外用药 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109602750A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1899291A (zh) * | 2006-07-24 | 2007-01-24 | 昆明滇虹药业有限公司 | 外用抗真菌的复方组合物及其应用 |
CN101618042A (zh) * | 2008-07-01 | 2010-01-06 | 江燕 | 一种治疗疱疹及神经性皮炎的药物 |
CN103402510A (zh) * | 2010-12-20 | 2013-11-20 | 安德鲁·图安·安·勒 | 用于治疗皮肤病症的组合物 |
-
2018
- 2018-10-25 CN CN201811272875.1A patent/CN109602750A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1899291A (zh) * | 2006-07-24 | 2007-01-24 | 昆明滇虹药业有限公司 | 外用抗真菌的复方组合物及其应用 |
CN101618042A (zh) * | 2008-07-01 | 2010-01-06 | 江燕 | 一种治疗疱疹及神经性皮炎的药物 |
CN103402510A (zh) * | 2010-12-20 | 2013-11-20 | 安德鲁·图安·安·勒 | 用于治疗皮肤病症的组合物 |
Non-Patent Citations (3)
Title |
---|
吴燕等: "复方盐酸特比萘芬凝胶抗皮肤癣菌感染的组织病理学疗效观察", 《中国真菌学杂志》 * |
王璐璐等: "2013~2015 年南京地区常用抗真菌药利用分析", 《中国药师》 * |
简卫东: "曲咪新乳膏治疗小儿念珠菌皮炎112例疗效观察", 《中国现代药物应用》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
McQuestion | Evidence-based skin care management in radiation therapy: clinical update | |
CN108853312B (zh) | 聚桂醇外用凝胶及其制备方法 | |
CN101417060B (zh) | 一种治疗外伤、跌打、斑秃及烧烫伤的药膏 | |
CN101785836B (zh) | 一种治疗皮肤病的中药膏剂及其制备方法和应用 | |
CN107233420A (zh) | 一种具有舒筋活络的足浴中药组合物及其制备方法和应用 | |
Waheed et al. | Tinea corporis resolution by homoeopathy: a case report | |
CN109602750A (zh) | 一种治疗皮肤病的外用药 | |
CN102949502B (zh) | 一种治疗头皮毛囊炎的外用中药 | |
CN104208295A (zh) | 一种烫伤药 | |
YAGHOUBI et al. | Olmsted syndrome in an Iranian family: report of two new cases | |
CN100370998C (zh) | 一种治疗诸般疮症、红伤、烧烫伤的中药制剂 | |
EP2712613B1 (en) | Vitamin K1 and uses thereof | |
CN103816233A (zh) | 一种治疗白癜风不完全性白斑的外用中药组合物 | |
CN101229263B (zh) | 一种治疗牛皮癣的中药 | |
Pérez et al. | Prevention and treatment of radiodermatitis using a nonadhesive foam dressing. | |
Vuopala et al. | Dimethyl Sulfoxide (DMSO) Ointment in the Treatment of Rheumatoid Arthritis: A Double Blind Study | |
CN103623007B (zh) | 一种治疗头皮癣的外用药膏及其制备和使用方法 | |
CN103356851B (zh) | 一种治疗褥疮的外用药物 | |
CN101596297B (zh) | 癣愈丸 | |
CN106166287A (zh) | 一种用于治疗皮肤瘙痒的中药 | |
CN107375422A (zh) | 治疗部分卡他症状外敷药物及其制作方法 | |
MacFarlane et al. | Treatment of inflamed fungal skin infections | |
CN104383274A (zh) | 一种防治痔疮手术后感染的中药组合物 | |
Soni et al. | Ayurvedic Treatment of Vipadika (Kshudra Kushtha) in Pediatric age-A Case Study | |
CN104606295A (zh) | 非抗生素类抗真菌外用药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190412 |
|
RJ01 | Rejection of invention patent application after publication |